MED29 and non-small cell lung carcinoma: In our previous work, we found that As-tDR-007333 promoted non-small cell lung cancer (NSCLC) malignancy through regulating H3K4me1 and H3K27ac modifications and augmenting ELK4-mediated MED29 transcription [22].